|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Medical Research Laboratory and Medical Department M(Endocrinology and Diabetes), Aarhus University Hospital, Aarhus Kommunehospital, Aarhus, Denmark
2 Medical Research Laboratory and Medical Department M(Endocrinology and Diabetes), Aarhus University Hospital, Aarhus Kommunehospital, Aarhus, Denmark; Department of Clinical Pharmacology, University of Aarhus, Aarhus, Denmark
* To whom correspondence should be addressed. E-mail: SL{at}Dadlnet.dk.
Physical activity is known to increase insulin action in skeletal muscle and data have indicated that 5'-AMP-activated protein kinase (AMPK) is involved in the molecular mechanisms behind this beneficial effect. 5-aminoimidazole-4-carboxamide-1-
-D-ribofuranoside (AICAR) can be used as a pharmacological tool to repeatedly activate AMPK, and the objective of this study was to explore whether the increase in insulin stimulated glucose uptake after either long-term exercise or chronic AICAR-administration was followed by fiber-type specific changes in insulin signaling and/or changes in GLUT4-expression. Wistar rats were allocated into three groups: an exercise-group trained on treadmill for 5 days, an AICAR-group exposed to daily subcutaneously injections of AICAR, and a sedentary control-group. AMPK activity, insulin-stimulated glucose transport, insulin signaling, and GLUT4 expression were determined in muscles characterized by different fiber-type compositions. Both exercised and AICAR-injected animals displayed a fiber-type specific increase in glucose transport with the most marked increase in muscles with a high content of type IIb fibers. This increase was accompanied by a concomitant increase in GLUT4 expression. Insulin signaling as assessed by PI3-kinase and PKB/Akt activity was only enhanced after AICAR administration and this in a non fiber-type specific manner. In conclusion, chronic AICAR-administration and long-term exercise both improve insulin stimulated glucose transport in skeletal muscle in a fiber-type specific way and this is associated with an increase in GLUT4 content.
This article has been cited by other articles:
![]() |
S. J. Lessard, D. A. Rivas, Z.-P. Chen, B. J. van Denderen, M. J. Watt, L. G. Koch, S. L. Britton, B. E. Kemp, and J. A. Hawley Impaired Skeletal Muscle {beta}-Adrenergic Activation and Lipolysis Are Associated with Whole-Body Insulin Resistance in Rats Bred for Low Intrinsic Exercise Capacity Endocrinology, November 1, 2009; 150(11): 4883 - 4891. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Alkhateeb, A. Chabowski, J. F. C. Glatz, B. Gurd, J. J. F. P. Luiken, and A. Bonen Restoring AS160 phosphorylation rescues skeletal muscle insulin resistance and fatty acid oxidation while not reducing intramuscular lipids Am J Physiol Endocrinol Metab, November 1, 2009; 297(5): E1056 - E1066. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Park, T. L. Scheffler, A. M. Gunawan, H. Shi, C. Zeng, K. M. Hannon, A. L. Grant, and D. E. Gerrard Chronic elevated calcium blocks AMPK-induced GLUT-4 expression in skeletal muscle Am J Physiol Cell Physiol, January 1, 2009; 296(1): C106 - C115. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. K. McConell, A. Manimmanakorn, R. S. Lee-Young, B. E. Kemp, K. C. Linden, and G. D. Wadley Differential attenuation of AMPK activation during acute exercise following exercise training or AICAR treatment J Appl Physiol, November 1, 2008; 105(5): 1422 - 1427. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Fujii, R. C. Ho, Y. Manabe, N. Jessen, T. Toyoda, W. L. Holland, S. A. Summers, M. F. Hirshman, and L. J. Goodyear Ablation of AMP-Activated Protein Kinase {alpha}2 Activity Exacerbates Insulin Resistance Induced by High-Fat Feeding of Mice Diabetes, November 1, 2008; 57(11): 2958 - 2966. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Feng, L. Gao, Q. Guan, X. Hou, Q. Wan, X. Wang, and J. Zhao Long-term moderate ethanol consumption restores insulin sensitivity in high-fat-fed rats by increasing SLC2A4 (GLUT4) in the adipose tissue by AMP-activated protein kinase activation J. Endocrinol., October 1, 2008; 199(1): 95 - 104. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Pandke, K. L. Mullen, L. A. Snook, A. Bonen, and D. J. Dyck Decreasing intramuscular phosphagen content simultaneously increases plasma membrane FAT/CD36 and GLUT4 transporter abundance Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2008; 295(3): R806 - R813. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Minge, B. D. Bennett, R. J. Norman, and R. L. Robker Peroxisome Proliferator-Activated Receptor-{gamma} Agonist Rosiglitazone Reverses the Adverse Effects of Diet-Induced Obesity on Oocyte Quality Endocrinology, May 1, 2008; 149(5): 2646 - 2656. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sato, M. Iemitsu, K. Aizawa, and R. Ajisaka Testosterone and DHEA activate the glucose metabolism-related signaling pathway in skeletal muscle Am J Physiol Endocrinol Metab, May 1, 2008; 294(5): E961 - E968. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Thomson, S. T. Herway, N. Fillmore, H. Kim, J. D. Brown, J. R. Barrow, and W. W. Winder AMP-activated protein kinase phosphorylates transcription factors of the CREB family J Appl Physiol, February 1, 2008; 104(2): 429 - 438. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Smith, K. L. Mullen, K. A. Junkin, J. Nickerson, A. Chabowski, A. Bonen, and D. J. Dyck Metformin and exercise reduce muscle FAT/CD36 and lipid accumulation and blunt the progression of high-fat diet-induced hyperglycemia Am J Physiol Endocrinol Metab, July 1, 2007; 293(1): E172 - E181. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Guha, S. Srinivasan, G. Biswas, and N. G. Avadhani Activation of a Novel Calcineurin-mediated Insulin-like Growth Factor-1 Receptor Pathway, Altered Metabolism, and Tumor Cell Invasion in Cells Subjected to Mitochondrial Respiratory Stress J. Biol. Chem., May 11, 2007; 282(19): 14536 - 14546. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Suwa, T. Egashira, H. Nakano, H. Sasaki, and S. Kumagai Metformin increases the PGC-1{alpha} protein and oxidative enzyme activities possibly via AMPK phosphorylation in skeletal muscle in vivo J Appl Physiol, December 1, 2006; 101(6): 1685 - 1692. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Al-Khalili, K. Bouzakri, S. Glund, F. Lonnqvist, H. A. Koistinen, and A. Krook Signaling Specificity of Interleukin-6 Action on Glucose and Lipid Metabolism in Skeletal Muscle Mol. Endocrinol., December 1, 2006; 20(12): 3364 - 3375. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Fujii, N. Jessen, and L. J. Goodyear AMP-activated protein kinase and the regulation of glucose transport Am J Physiol Endocrinol Metab, November 1, 2006; 291(5): E867 - E877. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sriwijitkamol, J. L. Ivy, C. Christ-Roberts, R. A. DeFronzo, L. J. Mandarino, and N. Musi LKB1-AMPK signaling in muscle from obese insulin-resistant Zucker rats and effects of training Am J Physiol Endocrinol Metab, May 1, 2006; 290(5): E925 - E932. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Horman, D. Vertommen, R. Heath, D. Neumann, V. Mouton, A. Woods, U. Schlattner, T. Wallimann, D. Carling, L. Hue, et al. Insulin Antagonizes Ischemia-induced Thr172 Phosphorylation of AMP-activated Protein Kinase {alpha}-Subunits in Heart via Hierarchical Phosphorylation of Ser485/491 J. Biol. Chem., March 3, 2006; 281(9): 5335 - 5340. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Smith, P. B. Patil, and J. S. Fisher AICAR and hyperosmotic stress increase insulin-stimulated glucose transport J Appl Physiol, September 1, 2005; 99(3): 877 - 883. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Smith, C. R. Bruce, and D. J. Dyck AMP kinase activation with AICAR simultaneously increases fatty acid and glucose oxidation in resting rat soleus muscle J. Physiol., June 1, 2005; 565(2): 537 - 546. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. P Wojtaszewski, J. B Birk, C. Frosig, M. Holten, H. Pilegaard, and F. Dela 5'AMP activated protein kinase expression in human skeletal muscle: effects of strength training and type 2 diabetes J. Physiol., April 15, 2005; 564(2): 563 - 573. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Pold, L. S. Jensen, N. Jessen, E. S. Buhl, O. Schmitz, A. Flyvbjerg, N. Fujii, L. J. Goodyear, C. F. Gotfredsen, C. L. Brand, et al. Long-Term AICAR Administration and Exercise Prevents Diabetes in ZDF Rats Diabetes, April 1, 2005; 54(4): 928 - 934. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Peres, S. M. F. de Moraes, C. E. M. Costa, L. C. Brito, J. Takada, S. Andreotti, M. A. Machado, M. I. C. Alonso-Vale, C. N. Borges-Silva, and F. B. Lima Endurance exercise training increases insulin responsiveness in isolated adipocytes through IRS/PI3-kinase/Akt pathway J Appl Physiol, March 1, 2005; 98(3): 1037 - 1043. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Thomson and S. E. Gordon Diminished overload-induced hypertrophy in aged fast-twitch skeletal muscle is associated with AMPK hyperphosphorylation J Appl Physiol, February 1, 2005; 98(2): 557 - 564. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. B. Taylor, D. Hurst, L. J. Greenwood, J. D. Lamb, T. D. Cline, S. N. Sudweeks, and W. W. Winder Endurance training increases LKB1 and MO25 protein but not AMP-activated protein kinase kinase activity in skeletal muscle Am J Physiol Endocrinol Metab, December 1, 2004; 287(6): E1082 - E1089. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Iglesias, S. M. Furler, G. J. Cooney, E. W. Kraegen, and J.-M. Ye AMP-Activated Protein Kinase Activation by AICAR Increases Both Muscle Fatty Acid and Glucose Uptake in White Muscle of Insulin-Resistant Rats In Vivo Diabetes, July 1, 2004; 53(7): 1649 - 1654. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Shearer, P. T. Fueger, B. Vorndick, D. P. Bracy, J. N. Rottman, J. A. Clanton, and D. H. Wasserman AMP Kinase-Induced Skeletal Muscle Glucose But Not Long-Chain Fatty Acid Uptake Is Dependent on Nitric Oxide Diabetes, June 1, 2004; 53(6): 1429 - 1435. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Frosig, S. B. Jorgensen, D. G. Hardie, E. A. Richter, and J. F. P. Wojtaszewski 5'-AMP-activated protein kinase activity and protein expression are regulated by endurance training in human skeletal muscle Am J Physiol Endocrinol Metab, March 1, 2004; 286(3): E411 - E417. [Abstract] [Full Text] |
||||
![]() |
J. Kim, R. S. Solis, E. B. Arias, and G. D. Cartee Postcontraction insulin sensitivity: relationship with contraction protocol, glycogen concentration, and 5' AMP-activated protein kinase phosphorylation J Appl Physiol, February 1, 2004; 96(2): 575 - 583. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yu, N. Fujii, M. F. Hirshman, J. M. Pomerleau, and L. J. Goodyear Cloning and characterization of mouse 5'-AMP-activated protein kinase {gamma}3 subunit Am J Physiol Cell Physiol, February 1, 2004; 286(2): C283 - C292. [Abstract] [Full Text] |
||||
![]() |
M. Mahlapuu, C. Johansson, K. Lindgren, G. Hjalm, B. R. Barnes, A. Krook, J. R. Zierath, L. Andersson, and S. Marklund Expression profiling of the {gamma}-subunit isoforms of AMP-activated protein kinase suggests a major role for {gamma}3 in white skeletal muscle Am J Physiol Endocrinol Metab, February 1, 2004; 286(2): E194 - E200. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Suwa, H. Nakano, and S. Kumagai Effects of chronic AICAR treatment on fiber composition, enzyme activity, UCP3, and PGC-1 in rat muscles J Appl Physiol, September 1, 2003; 95(3): 960 - 968. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |